Telomir Advances Telomir-Zn in Human and Canine Osteosarcoma
MIAMI, Fla. — September 14, 2026 Telomir Pharmaceuticals, Inc. announced new research conducted with The Ohio State University College...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MIAMI, Fla. — September 14, 2026 Telomir Pharmaceuticals, Inc. announced new research conducted with The Ohio State University College...
SAN LEANDRO, Calif., July 7, 2026 WAVES Veterinary Emergency & Specialty Hospital has officially opened its doors in San...
Rockville, Maryland, June 26, 2026 OS Animal Health announced the peer-reviewed publication of Phase 2 clinical trial results evaluating...
ROCKVILLE, MD — November 20, 2025 — OS Therapies announced the strategic spin-off of OS Animal Health, establishing it...
